 Eiger BioPharmaceuticals, Inc. Nasdaq: EIGR, focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today provided an update on the impact of the rapidly progressing global COVID-19 SARS-CoV-2 pandemic. Eiger has put into place remote operations 